Search results for "Follow-up studies"

showing 10 items of 2210 documents

Possible Role of the Posterior Compartment Peritonectomy, as a Part of the Complex Surgery, Regarding Recurrence Rate, Improvement of Symptoms and Fe…

2020

ABSTRACT Study Objective Beside the pain, there are 2 further problems in the management of endometriosis: the high recurrence rate (10% per year) and the high rate of impaired fertility. The objective of this study was to investigate the pathogenesis of these 2 factors. Design This is a retrospective cohort study, and the aim is to evaluate the complete excision of endometriotic lesions, including the posterior compartment of the peritoneum, with regard to postoperative outcome, focusing on relieving pain, increasing fertility rate, and decreasing recurrence rate. Setting Charite-University Clinic, Department of Gynaecology, Endometriosis research Centre. Patients Fifty-four patients were …

Pregnancy RateEndometriosisPilot ProjectsPeritoneal DiseasesEndoscopy Gastrointestinal0302 clinical medicinePostoperative ComplicationsPeritonectomyPregnancyRecurrencePostoperative PeriodEndometriosiLaparoscopyBirth Ratemedia_common030219 obstetrics & reproductive medicinemedicine.diagnostic_testObstetrics and GynecologyPeritonectomyTreatment Outcome030220 oncology & carcinogenesisFemaleRecurrence ratemedicine.symptomPeritoneumInfertilityAdultReoperationmedicine.medical_specialtymedia_common.quotation_subjectEndometriosisFertilityPelvic Pain03 medical and health sciencesmedicineHumansLong-term follow-upRetrospective StudiesPregnancybusiness.industryPelvic painRetrospective cohort studymedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaSurgeryFertilityInfertilityLaparoscopyPosterior compartment peritoneumbusinessFollow-Up StudiesJournal of minimally invasive gynecology
researchProduct

Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase

2015

Proteomics analysis of paired cancer and control tissue can be applied to investigate pathological processes in tumors. Advancements in data-independent acquisition mass spectrometry allow for highly reproducible quantitative analysis of complex proteomic patterns. Optimized sample preparation workflows enable integrative multi-omics studies from the same tissue specimens. We performed ion mobility enhanced, data-independent acquisition MS to characterize the proteome of 21 lung tumor tissues including adenocarcinoma and squamous cell carcinoma (SCC) as compared to control lung tissues of the same patient each. Transcriptomic data were generated for the same specimens. The quantitative prot…

Proteomics0301 basic medicinePathologymedicine.medical_specialtyLung NeoplasmsProteomeSystems biologyProteomicsTranscriptometranscriptomics03 medical and health sciencesBiomarkers TumormedicineHumansLung cancerNeoplasm Stagingmass spectrometryadenocarcinomabusiness.industryGene Expression Profilingproteomics analysisPrognosismedicine.diseaseGene expression profiling030104 developmental biologyOncologyCase-Control StudiesProteomeCarcinoma Squamous CellAdenocarcinomalung tumorsTranscriptomebusinessQuantitative analysis (chemistry)Follow-Up StudiesResearch PaperOncotarget
researchProduct

Protective effect of smoking: misleading use of statistics.

2004

PsychiatryLegbusiness.industryScienceArterial Occlusive DiseasesConfounding Factors EpidemiologicsmokingvascularizationRecurrenceEnvironmental healthHumansMedicineRadiology Nuclear Medicine and imagingProspective StudiesbusinessII errorAngioplasty BalloonFollow-Up Studies
researchProduct

The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design.

2021

Up to 80% of first-episode psychosis patients suffer a relapse within five years of the remission. Relapse should be an important focus of prevention given the potential harm to the patient and family. It threatens to disrupt their psychosocial recovery, increases the risk of resistance to treatment and has been associated with greater direct and indirect costs for society. Based on a previous project entitled "Genotype-phenotype and environment. Application to a predictive model in first psychotic episodes" (PEPs Project), the project "Clinical and neurobiological determinants of second episodes of schizophrenia. Longitudinal study of first episode of psychosis" was designed, also known as…

PsychosisLongitudinal studymedicine.medical_specialtyIndirect costs03 medical and health sciences0302 clinical medicineRecurrenceIntervention (counseling)medicineHumansLongitudinal StudiesPsychiatryFirst episodebusiness.industryNeuropsychologyGeneral Medicinemedicine.disease030227 psychiatryPsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniabusinessPsychosocial030217 neurology & neurosurgeryFollow-Up StudiesRevista de psiquiatria y salud mental
researchProduct

Naturalistic follow-up study of rehospitalization rates and assigned disability status of patients with first-episode schizophrenia spectrum psychosi…

2020

Patients with first-episode schizophrenia spectrum psychosis (FEP) are at risk of not visiting an out-patient psychiatrist and are assigned disability status within a short period after diagnosis.The aim of this study was to conduct a naturalistic follow-up of FEP patients to explore their use of mental healthcare services and the rate of assigned disability status after FEP.This was the first study in Latvia to include all consecutive patients with FEP admitted to the largest regional hospital in South East Latvia, Daugavpils Psychoneurological Hospital (DPNH). Patients received standard treatment in a real-world environment. The mean follow-up time was 33 months (Min = 20 months, Max = 40…

Psychosismedicine.medical_specialtybusiness.industryFollow up studiesFirst episode schizophreniamedicine.diseasebehavioral disciplines and activitiesLatviaHospitalizationPsychiatry and Mental healthPsychotic DisordersSchizophreniamental disordersSouth eastmedicineSchizophreniaHumansPsychiatrybusinessSchizophrenia spectrumFollow-Up StudiesNordic journal of psychiatry
researchProduct

Retrograde in situ versus antegrade pulmonary preservation in clinical lung transplantation: a single-centre experience.

2014

OBJECTIVE Experimental and clinical studies have indicated a beneficial effect of retrograde lung preservation on post-transplant results. Accordingly, we conducted a non-randomized trial. METHODS A total of 209 consecutive recipients transplanted with low-potassium dextrane (LPD)-preserved lungs were eligible for analysis. Antegrade lung preservation (AP) was performed in 173 patients and retrograde in situ perfusion (RP) in 36 patients using low-potassium dextrane solution in all cases. The prostacycline was added to preservation solution. RESULTS The main donor, graft and recipient characteristics did not differ significantly between groups. There was a beneficial trend toward improved o…

Pulmonary and Respiratory MedicineAdultGraft RejectionMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentOrgan Preservation SolutionsUrologyPrimary Graft DysfunctionBronchiolitis obliteransKaplan-Meier Estimate030204 cardiovascular system & hematologyRisk AssessmentStatistics NonparametricCohort Studies03 medical and health sciences0302 clinical medicinemedicineLung transplantationHumansProportional Hazards ModelsRetrospective StudiesLungbusiness.industryIncidence (epidemiology)Graft SurvivalGeneral MedicineOxygenationOrgan PreservationMiddle Agedmedicine.diseaseSurvival AnalysisTissue DonorsTransplantationmedicine.anatomical_structureTreatment Outcome030228 respiratory systemCohortMultivariate AnalysisSurgeryFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesLung TransplantationEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Bidirectional Glenn and antegrade pulmonary blood flow: temporary or definitive palliation?

2008

Background We sought to investigate the role of the bidirectional Glenn with antegrade pulmonary blood flow in the surgical history of children with univentricular hearts. Methods A series of 246 patients, from three joint institutions, having univentricular heart with restricted but not critical pulmonary blood flow received a bidirectional cavopulmonary shunt with additional forward pulmonary blood flow. All patients have been studied according to their progression, or not, to Fontan operation. Two hundred and eight (84.5%) patients underwent bidirectional cavopulmonary anastomosis as primary palliation. Twenty patients (8.1%) with previous pulmonary artery banding were also enrolled in t…

Pulmonary and Respiratory MedicineAdultHeart Defects CongenitalMalemedicine.medical_specialtyPulmonary CirculationAdolescentHeart VentriclesHemodynamicsKaplan-Meier EstimateHematocritFontan ProcedureRisk AssessmentSensitivity and SpecificityPulmonary artery bandingCohort StudiesArteriovenous Shunt SurgicalInternal medicinemedicineHumansHeart bypassChildSurvival rateRetrospective StudiesLungmedicine.diagnostic_testbusiness.industryHeart Bypass RightPalliative CareInfantBlood flowSurgerySurvival Ratemedicine.anatomical_structureTreatment OutcomeChild PreschoolCirculatory systemCardiologyLinear ModelsSurgeryFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesThe Annals of thoracic surgery
researchProduct

Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma.

2009

Background The worldwide increased prevalence of allergic diseases, and especially of respiratory allergy, is paralleled by increased health costs. This requires consideration of the cost to efficacy ratio of the available treatment to identify the optimal choice. Objective To compare the different economic relevance, over a long evaluation time, of symptomatic pharmacologic therapy and sublingual immunotherapy (SLIT) in patients with allergic asthma. Methods Seventy patients with perennial allergic asthma, sensitized to dust mites, were enrolled; 50 of these patients were treated with SLIT against house dust mites and 20 were treated with symptomatic drugs. The patients were evaluated for …

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAllergyAdolescentCost-Benefit AnalysisImmunologyPopulationAdministration SublingualFollow-Up StudieSublingual administrationDrug TherapyImmunopathologyInternal medicinemedicineImmunology and AllergyHumansCost-Benefit AnalysieducationChildAsthmaeducation.field_of_studyDrug Therapy; Combined Modality Therapy; Immunotherapy; Humans; Asthma; Child; Health Care Costs; Cost-Benefit Analysis; Adult; Middle Aged; Follow-Up Studies; Adolescent; Administration Sublingual; Male; Femalebusiness.industryRespiratory diseaseHealth Care CostsMiddle Agedmedicine.diseaseSlitCombined Modality TherapyAsthmaSurgeryHealth Care CostObservational studyFemaleImmunotherapybusinessHumanFollow-Up StudiesAnnals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology
researchProduct

Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma.

2010

Omalizumab is approved for the treatment of severe allergic asthma.To compare the efficacy of omalizumab therapy in patients 50 years or older with patients younger than 50 years.Between November 2005 and November 2007 a total of 174 asthma patients 50 years or older (40.7% male, 51.1% taking oral corticosteroids, and mean [SD] serum IgE level of 315 [353] U/L) and 297 asthma patients younger than 50 years (40.0% male, 50.5% taking oral corticosteroids, and mean [SD] serum IgE level of 363 [431] U/L) who met the European Union criteria for add-on therapy with anti-IgE were treated prospectively with omalizumab for 4 months as part of 2 postmarketing surveillance trials.Compared with the pre…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAllergyPediatricsAdolescentImmunologyPostmarketing surveillanceOmalizumabOmalizumabImmunoglobulin EAntibodies Monoclonal HumanizedGermanymedicineProduct Surveillance PostmarketingImmunology and Allergymedia_common.cataloged_instanceHumansAnti-Asthmatic AgentsEuropean unionAdverse effectChildmedia_commonAsthmaAgedbiologybusiness.industryAge FactorsAntibodies MonoclonalImmunoglobulin EMiddle Agedmedicine.diseaseAsthmaSurgeryDiscontinuationAntibodies Anti-IdiotypicRespiratory Function Testsbiology.proteinDisease ProgressionFemalebusinessmedicine.drugFollow-Up StudiesAnnals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology
researchProduct

Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma.

2002

The ability of omalizumab, an anti-immnoglobulin-E agent, to maintain long-term disease control in patients with moderate-to-severe allergic asthma was investigated in a 24-week double-blind extension to a 28-week core trial. During the extension, 483 of the initial 546 patients were maintained on randomised treatment and the lowest sustainable dose of beclomethasone dipropionate (BDP) as established during the steroid-reduction phase of the core trial. The use of concomitant asthma medication was permitted and investigators were allowed to adjust the BDP dose or switch patients from BDP to other asthma medications if deemed necessary. More omalizumab-treated patients (33.5%) than placebo-t…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAllergyTime FactorsAdolescentOmalizumabOmalizumabImmunoglobulin EPlaceboAntibodies Monoclonal HumanizedSeverity of Illness Indexlaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineHypersensitivityHumansAnti-Asthmatic AgentsAdverse effectChildAsthmaAgedbiologyDose-Response Relationship Drugbusiness.industryBeclomethasoneAntibodies MonoclonalMiddle Agedmedicine.diseaseAsthmaSurgeryAntibodies Anti-IdiotypicTreatment OutcomeConcomitantbiology.proteinFemalebusinessmedicine.drugFollow-Up StudiesThe European respiratory journal
researchProduct